Anika Therapeutics (ANIK) to Release Earnings on Wednesday

Anika Therapeutics (NASDAQ:ANIK) is anticipated to release its earnings data after the market closes on Wednesday, March 12th. Analysts expect Anika Therapeutics to post earnings of ($0.01) per share and revenue of $29.00 million for the quarter. Investors interested in registering for the company’s conference call can do so using this link.

Anika Therapeutics Trading Down 0.7 %

Shares of NASDAQ:ANIK opened at $16.50 on Tuesday. The company has a 50 day moving average of $16.91 and a 200-day moving average of $19.73. The firm has a market cap of $241.66 million, a P/E ratio of -2.48 and a beta of 0.95. Anika Therapeutics has a twelve month low of $15.40 and a twelve month high of $29.11.

About Anika Therapeutics

Anika Therapeutics, Inc, a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.